Pancreatic Endocrine Tumors: Radiologic-Clinicopathologic Correlation

References

• 1 Nicholls AG. Simple adenoma of the pancreas arising from an island of Langerhans. J Med Res 1902; 8(2):385–395.
  MedlineGoogle Scholar
• 2 Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. In: Silverberg SGSobin LH, eds. AFIP atlas of tumor pathology. 4th ed. Washington, DC: American Registry of Pathology, 2007.
  Google Scholar
• 3 Klöppel G, Anlauf M. Pancreatic endocrine tumors. Pathol Case Rev 2006;11(6):256–267.
  Google Scholar
• 4 Wilder RM, Allan FN, Power MH, Robertson HE. Carcinoma of the islands of the pancreas: hyperinsulinism and hypoglycemia. J Am Med Assoc 1927;89(5):348–355.
  Google Scholar
• 5 Heitz PU, Komminoth P, Perren A, et al.. Pancreatic endocrine tumours: introduction. In: DeLellis RALloyd RVHeitz PUEng C, eds. World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. Lyon, France: IARC, 2004; 177–182.
  Google Scholar
• 6 Malagò R, D'Onofrio M, Zamboni GA, et al.. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. AJR Am J Roentgenol 2009;192(2):424–430.
  MedlineGoogle Scholar
• 7 Buetow PC, Parrino TV, Buck JL, et al.. Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR Am J Roentgenol 1995;165(5):1175–1179.
  MedlineGoogle Scholar
• 8 Volkan Adsay N. Cystic lesions of the pancreas. Mod Pathol 2007;20(suppl 1):S71–S93.
  MedlineGoogle Scholar
• 9 Heitz PU, Kasper M, Polak JM, Klöppel G. Pancreatic endocrine tumors. Hum Pathol 1982;13(3):263–271.
  MedlineGoogle Scholar
• 10 Hochwald SN, Zee S, Conlon KC, et al.. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002;20(11):2633–2642.
  MedlineGoogle Scholar
• 11 Pitre J, Soubrane O, Palazzo L, Chapuis Y. Endoscopic ultrasonography for the preoperative localization of insulinomas. Pancreas 1996;13(1):55–60.
  MedlineGoogle Scholar
• 12 Buetow PC, Miller DL, Parrino TV, Buck JL. Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. RadioGraphics 1997;17(2):453–472.
  Google Scholar
• 13 Fidler JL, Fletcher JG, Reading CC, et al.. Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol 2003;181(3):775–780.
  MedlineGoogle Scholar
• 14 Mansour JC, Chen H. Pancreatic endocrine tumors. J Surg Res 2004;120(1):139–161.
  MedlineGoogle Scholar
• 15 Zimmer T, Scherübl H, Faiss S, Stölzel U, Riecken EO, Wiedenmann B. Endoscopic ultrasonography of neuroendocrine tumours. Digestion 2000;62(suppl 1): 45–50.
  MedlineGoogle Scholar
• 16 Ligneau B, Lombard-Bohas C, Partensky C, et al.. Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases. Am J Surg Pathol 2001;25(6):752–760.
  MedlineGoogle Scholar
• 17 Gouya H, Vignaux O, Augui J, et al.. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 2003;181(4):987–992.
  MedlineGoogle Scholar
• 18 Stafford-Johnson DB, Francis IR, Eckhauser FE, Knol JA, Chang AE. Dual-phase helical CT of nonfunctioning islet cell tumors. J Comput Assist Tomogr 1998;22(2):335–339.
  MedlineGoogle Scholar
• 19 King AD, Ko GT, Yeung VT, Chow CC, Griffith J, Cockram CS. Dual phase spiral CT in the detection of small insulinomas of the pancreas. Br J Radiol 1998;71(841):20–23.
  MedlineGoogle Scholar
• 20 Horton KM, Hruban RH, Yeo C, Fishman EK. Multi-detector row CT of pancreatic islet cell tumors. RadioGraphics 2006;26(2):453–464.
  Google Scholar
• 21 Ichikawa T, Peterson MS, Federle MP, et al.. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 2000;216(1):163–171.
  Google Scholar
• 22 Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000;214(2):483–490.
  Google Scholar
• 23 Semelka RC, Custodio CM, Cem Balci N, Woosley JT. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 2000;11(2):141–148.
  MedlineGoogle Scholar
• 24 Huppertz A, Haraida S, Kraus A, et al.. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT—initial observations. Radiology 2005;234(2):468–478.
  Google Scholar
• 25 Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med 2006;36(3):228–247.
  MedlineGoogle Scholar
• 26 Whipple AO, Frantz VK. Adenoma of islet cells with hyperinsulinism: a review. Ann Surg 1935;101(6):1299–1335.
  MedlineGoogle Scholar
• 27 Chung MJ, Choi BI, Han JK, Chung JW, Han MC, Bae SH. Functioning islet cell tumor of the pancreas: localization with dynamic spiral CT. Acta Radiol 1997;38(1):135–138.
  MedlineGoogle Scholar
• 28 Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955;142(4):709–723; discussion, 724–728.
  MedlineGoogle Scholar
• 29 Gregory RA, Tracy HJ, French JM, Sircus W. Extraction of a gastrin-like substance from a pancreatic tumour in a case of Zollinger-Ellison syndrome. Lancet 1960;1(7133):1045–1048.
  MedlineGoogle Scholar
• 30 Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Derm Syphilol 1942;45(6):1069–1080.
  Google Scholar
• 31 McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME. A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 1966;274(25):1408–1413.
  MedlineGoogle Scholar
• 32 Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001;321(5):306–320.
  MedlineGoogle Scholar
• 33 Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958;25(3):374–380.
  MedlineGoogle Scholar
• 34 Bloom SR, Polak JM, Pearse AG. Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet 1973;2(7819):14–16.
  MedlineGoogle Scholar
• 35 Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg 2008;12(2):382–393.
  MedlineGoogle Scholar
• 36 Soga J, Yakuwa Y. Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 1998;17(4):389–400.
  MedlineGoogle Scholar
• 37 Larsson LI, Hirsch MA, Holst JJ, et al.. Pancreatic somatostatinoma: clinical features and physiological implications. Lancet 1977;1(8013):666–668.
  MedlineGoogle Scholar
• 38 Soga J, Yakuwa Y. Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 1999;18(1):13–22.
  MedlineGoogle Scholar
• 39 Gullo L, Migliori M, Falconi M, et al.. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol 2003;98(11):2435–2439.
  MedlineGoogle Scholar
• 40 Ichikawa T, Federle MP, Ohba S, et al.. Atypical exocrine and endocrine pancreatic tumors (anaplastic, small cell, and giant cell types): CT and pathologic features in 14 patients. Abdom Imaging 2000;25(4):409–419.
  MedlineGoogle Scholar
• 41 Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954;16(3):363–371.
  MedlineGoogle Scholar
• 42 Kouvaraki MA, Shapiro SE, Cote GJ, et al.. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg 2006;30(5):643–653.
  MedlineGoogle Scholar
• 43 Scarsbrook AF, Thakker RV, Wass JA, Gleeson FV, Phillips RR. Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach. RadioGraphics 2006; 26(2):433–451.
  Google Scholar
• 44 Blansfield JA, Choyke L, Morita SY, et al.. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 2007;142(6):814–818; discussion 818.e1–818.e2.
  MedlineGoogle Scholar
• 45 Libutti SK, Choyke PL, Bartlett DL, et al.. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery 1998;124(6):1153–1159.
  MedlineGoogle Scholar
• 46 Edge SB, Byrd DR, Carducci MA, Compton CC. AJCC cancer staging manual. 7th ed. New York, NY: Springer, 2009.
  Google Scholar
• 47 Thompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery 1988;104(6):1011–1017.
  MedlineGoogle Scholar
• 48 Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma: incidence, recurrence, and long-term survival of patients—a 60-year study. Mayo Clin Proc 1991;66(7):711–719.
  MedlineGoogle Scholar
• 49 Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation 1998;66(10):1307–1312.
  MedlineGoogle Scholar
• 50 Steward MJ, Warbey VS, Malhotra A, Caplin ME, Buscombe JR, Yu D. Neuroendocrine tumors: role of interventional radiology in therapy. RadioGraphics 2008;28(4):1131–1145.
  Google Scholar